Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 729195, 11 pages
http://dx.doi.org/10.1155/2014/729195
Research Article

Da-Bu-Yin-Wan and Qian-Zheng-San to Neuroprotect the Mouse Model of Parkinson’s Disease

1Department of Anatomy, School of Preclinical Medicine, Beijing University of Chinese Medicine, No. 11 N. 3rd Ring Eastern Road, Beijing 100029, China
2Center of Scientific Research, School of Preclinical Medicine, Beijing University of Chinese Medicine, No. 11 N. 3rd Ring Eastern Road, Beijing 100029, China

Received 16 September 2014; Accepted 3 December 2014; Published 24 December 2014

Academic Editor: Kuttulebbai N. S. Sirajudeen

Copyright © 2014 Xiao-Gang Gong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Bisaglia, R. Filograna, M. Beltramini, and L. Bubacco, “Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?” Ageing Research Reviews, vol. 13, no. 1, pp. 107–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. L. S. Forno, “Neuropathology of Parkinson's disease,” Journal of Neuropathology and Experimental Neurology, vol. 55, no. 3, pp. 259–272, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Thomas and M. Flint Beal, “Parkinson's disease,” Human Molecular Genetics, vol. 16, no. 2, pp. R183–R194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Wheeler, C. Wang, K. Yang et al., “Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels,” Molecular Pharmacology, vol. 74, no. 5, pp. 1333–1344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Proks and F. M. Ashcroft, “Modeling KATP channel gating and its regulation,” Progress in Biophysics and Molecular Biology, vol. 99, no. 1, pp. 7–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Zini, E. Tremblay, H. Pollard, J. Moreau, and Y. Ben-Ari, “Regional distribution of sulfonylurea receptors in the brain of rodent and primate,” Neuroscience, vol. 55, no. 4, pp. 1085–1091, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. D. W. Busija, Z. Lacza, N. Rajapakse et al., “Targeting mitochondrial ATP-sensitive potassium channels—a novel approach to neuroprotection,” Brain Research Reviews, vol. 46, no. 3, pp. 282–294, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. H. V. Schapira, J. M. Cooper, D. Dexter, J. B. Clark, P. Jenner, and C. D. Marsden, “Mitochondrial complex I deficiency in Parkinson's disease,” Journal of Neurochemistry, vol. 54, no. 3, pp. 823–827, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Zhou, H. J. He, O. Tanaka, M. Sekiguchi, K. Kawahara, and H. Abe, “Localization of the ATP-sensitive K+ channel regulatory subunits SUR2A and SUR2B in the rat brain,” Neuroscience Research, vol. 74, no. 2, pp. 91–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. D. N. Hauser and T. G. Hastings, “Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism,” Neurobiology of Disease, vol. 51, pp. 35–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Liss, O. Haeckel, J. Wildmann, T. Miki, S. Seino, and J. Roeper, “K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons,” Nature Neuroscience, vol. 8, no. 12, pp. 1742–1751, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Lamensdorf, N. Meiri, J. Harvey-White, D. M. Jacobowitz, and I. J. Kopin, “Kir6.2 oligoantisense administered into the globus pallidus reduces apomorphine-induced turning in 6-OHDA hemiparkinsonian rats,” Brain Research, vol. 818, no. 2, pp. 275–284, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Yaguchi, S. Aida, S. C. Kaul, and R. Wadhwa, “Involvement of mortalin in cellular senescence from the perspective of its mitochondrial import, chaperone, and oxidative stress management functions,” Annals of the New York Academy of Sciences, vol. 1100, pp. 306–311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Inoue, H. Nagase, K. Kishi, and T. Higuti, “ATP-sensitive K+ channel in the mitochondrial inner membrane,” Nature, vol. 352, no. 6332, pp. 244–247, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Paucek, G. Mironova, F. Mahdi, A. D. Beavis, G. Woldegiorgis, and K. D. Garlid, “Reconstitution and partial purification of the glibenclamide-sensitive, ATP-dependent K+ channel from rat liver and beef heart mitochondria,” The Journal of Biological Chemistry, vol. 267, no. 36, pp. 26062–26069, 1992. View at Google Scholar · View at Scopus
  16. R. Bajgar, S. Seetharaman, A. J. Kowaltowski, K. D. Garlid, and P. Paucek, “Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain,” The Journal of Biological Chemistry, vol. 276, no. 36, pp. 33369–33374, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Kicinska, A. Swida, P. Bednarczyk et al., “ATP-sensitive potassium channel in mitochondria of the eukaryotic microorganism Acanthamoeba castellanii,” The Journal of Biological Chemistry, vol. 282, no. 24, pp. 17433–17441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Debska, A. Kicinska, J. Skalska et al., “Opening of potassium channels modulates mitochondrial function in rat skeletal muscle,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1556, no. 2-3, pp. 97–105, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Chemin, C. Girard, F. Duprat, F. Lesage, G. Romey, and M. Lazdunski, “Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K+ channels,” The EMBO Journal, vol. 22, no. 20, pp. 5403–5411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Bednarczyk, “Potassium channels in brain mitochondria,” Acta Biochimica Polonica, vol. 56, no. 3, pp. 385–392, 2009. View at Google Scholar · View at Scopus
  21. J. Zeng, G. Wang, and S.-D. Chen, “ATP-sensitive potassium channels: novel potential roles in Parkinson's disease,” Neuroscience Bulletin, vol. 23, no. 6, pp. 370–376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. L. Riess, A. K. S. Camara, A. Heinen, J. T. Eells, M. M. Henry, and D. F. Stowe, “KATP channel openers have opposite effects on mitochondrial respiration under different energetic conditions,” Journal of Cardiovascular Pharmacology, vol. 51, no. 5, pp. 483–491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Rodriguez-Pallares, J. A. Parga, B. Joglar, M. J. Guerra, and J. L. Labandeira-Garcia, “The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons,” Neurotoxicity Research, vol. 15, no. 1, pp. 82–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Yamada and N. Inagaki, “Neuroprotection by KATP channels,” Journal of Molecular and Cellular Cardiology, vol. 38, no. 6, pp. 945–949, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. X. X. Xie, S. T. Kou, Z. H. Pu, C. Y. Hou, and Y. P. Tian, “Treatment for Parkinson's disease—a literature review on Chinese medicine,” Health Vocational Education, vol. 23, no. 3, pp. 110–113, 2005. View at Google Scholar
  26. Y. P. Li and J. C. Feng, “Chinese prescription Da Bu Yin Wan—recent clinical progress,” Zhejiang Journal of Traditional Chinese Medicine, no. 7, pp. 314–316, 2000. View at Google Scholar
  27. Y. Zhang, H.-M. Sun, X. He et al., “Da-Bu-Yin-Wan and Qian-Zheng-San, two traditional Chinese herbal formulas, up-regulate the expression of mitochondrial subunit NADH dehydrogenase 1 synergistically in the mice model of Parkinson's disease,” Journal of Ethnopharmacology, vol. 146, no. 1, pp. 363–371, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. X. He, Y. S. Gao, H. M. Sun, H. X. Wu, H. Xu, and Z. Y. Wang, “Effect of Dabuyin Pill and Qianzheng Powder on activity of mitochondrial enzyme complexes in mice with Parkinson's disease,” Jiangsu Journal of Traditional Chinese Medicine, vol. 42, no. 9, pp. 72–73, 2010. View at Google Scholar
  29. X. He, H. M. Sun, H. X. Wu et al., “Neuroprotective effect Of Dabuyin Pill, Qianzheng Powder and combined formula on Parkinson's disease mice brain,” Liaoning Journal of Traditional Chinese Medicine, vol. 37, no. 11, pp. 2098–2101, 2010. View at Google Scholar
  30. E. C. Stack, J. L. Ferro, J. Kim et al., “Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease,” Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1782, no. 3, pp. 151–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. X. M. Li, H. B. Ma, Z.Q. Ma et al., “Ameliorative and neuroprotective effect in MPTP model of Parkinson's disease by Zhen-Wu-Tang (ZWT), a traditional Chinese medicine,” Journal of Ethnopharmacology, vol. 130, no. 1, pp. 19–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. J. Deng, Science of Chinese Medicinal Formula, China Press of Traditional Chinese Medicine, Beijing, China, 2010.
  33. N. Ogawa, Y. Hirose, S. Ohara, T. Ono, and Y. Watanabe, “A simple quantitative bradykinesia test in MPTP-treated mice,” Research Communications in Chemical Pathology and Pharmacology, vol. 50, no. 3, pp. 435–441, 1985. View at Google Scholar · View at Scopus
  34. J. Zhang, Q. J. Li, H. M. Sun, L. M. Bai, and T. J. Qiu, “Experimental study on treatment of Ginkgo Biloba Pingchan recipe and its diffrent combination on the behavioral test and morphology in the model mouse with parkins on disease,” Chinese Archives of Traditionl Chinese Medcine, vol. 26, no. 11, pp. 2348–2351, 2008. View at Google Scholar
  35. V. M. Pickel, T. H. Joh, P. M. Field, C. G. Becker, and D. J. Reis, “Cellular localization of tyrosine hydroxylase by immunohistochemistry,” Journal of Histochemistry and Cytochemistry, vol. 23, no. 1, pp. 1–12, 1975. View at Publisher · View at Google Scholar · View at Scopus
  36. J. M. Fritschy, “Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry,” European Journal of Neuroscience, vol. 28, no. 12, pp. 2365–2370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Y. Deutch and D. G. Winder, “A channel to neurodegeneration,” Nature Medicine, vol. 12, no. 1, pp. 17–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Hartmann, J. D. Troadec, S. Hunot et al., “Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis,” The Journal of Neuroscience, vol. 21, no. 7, pp. 2247–2255, 2001. View at Google Scholar · View at Scopus
  40. H. Yuan, J. C. Zheng, P. Liu, S. F. Zhang, J. Y. Xu, and L. M. Bai, “Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes,” Neuroscience Bulletin, vol. 23, no. 2, pp. 125–130, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Rodriguez-Pallares, J. A. Parga, B. Joglar, M. J. Guerra, and J. L. Labandeira-Garcia, “Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease,” Age, vol. 34, no. 4, pp. 863–880, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. D. G. Nicholls and S. L. Budd, “Mitochondria and neuronal survival,” Physiological Reviews, vol. 80, no. 1, pp. 315–360, 2000. View at Google Scholar · View at Scopus
  43. M. V. Avshalumov, B. T. Chen, T. Koos, J. M. Tepper, and M. E. Rice, “Endogenous hydrogen peroxide regulates the excitability of midbrain dopamine neurons via ATP-sensitive potassium channels,” The Journal of Neuroscience, vol. 25, no. 17, pp. 4222–4231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. M. V. Avshalumov, L. Bao, J. C. Patel, and M. E. Rice, “H2O2 signaling in the nigrostriatal dopamine pathway via ATP-sensitive potassium channels: issues and answers,” Antioxidants & Redox Signaling, vol. 9, no. 2, pp. 219–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Karschin, J. Brockhaus, and K. Ballanyi, “KATP channel formation by the sulphonylurea receptors SUR1 with Kir6.2 subunits in rat dorsal vagal neurons in situ,” The Journal of Physiology, vol. 509, p. 2, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. I. J. Kopin and S. P. Markey, “MPTP toxicity: implications for research in Parkinson's disease,” Annual Review of Neuroscience, vol. 11, pp. 81–96, 1988. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Porras, Q. Li, and E. Bezard, “Modeling Parkinson's disease in primates: the MPTP model,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 3, Article ID a9308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Przedborski, K. Tieu, C. Perier, and M. Vila, “MPTP as a mitochondrial neurotoxic model of Parkinson's disease,” Journal of Bioenergetics and Biomembranes, vol. 36, no. 4, pp. 375–379, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. J. N. Joyce, G. Smutzer, C. J. Whitty, A. Myers, and M. J. Bannon, “Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease,” Movement Disorders, vol. 12, no. 6, pp. 885–897, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Zhang, L. Huang, L. Chen, D. Hao, and J. Chen, “Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease,” Toxicology Letters, vol. 222, no. 2, pp. 155–163, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Matsuura, H. Kabuto, H. Makino, and N. Ogawa, “Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion,” Journal of Neuroscience Methods, vol. 73, no. 1, pp. 45–48, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Zhang and P. P. Li, “Shu-Gan-Liang-Xue Decoction, a Chinese herbal formula, down-regulates the expression of steroid sulfatase genes in human breast carcinoma MCF-7 cells,” Journal of Ethnopharmacology, vol. 127, no. 3, pp. 620–624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Kavitha, J. Nataraj, M. M. Essa, M. A. Memon, and T. Manivasagam, “Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice,” Chemico-Biological Interactions, vol. 206, no. 2, pp. 239–247, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. J. Zhang, Q. Q. Bao, G. S. Gao, S. Li, and J. Jiang, “The post-treatment action of chinonin on MPTP-induced mice model of Parkinson's disease,” Journal of Pharmaceutical and Biomedical Sciences, vol. 6, no. 4, pp. 536–544, 2014. View at Google Scholar
  55. N. Li, “Clinical observation on Parkinson's disease patients with treatement of traditional Chinese medicine,” Chinese Journal of Geriatric Care, vol. 7, pp. 100–101, 2009. View at Google Scholar
  56. B. E. Shan, J. Y. Zhang, and Q. X. Li, “Human T cell and monocyte modulating activity of Rhizoma typhonii in vitro,” Chinese Journal of Integrative Medicine, vol. 21, no. 10, pp. 768–772, 2001. View at Google Scholar · View at Scopus
  57. Z. Y. Xiao, S. M. Yin, D. Q. Yu, X. Gao, J. Zhao, and W. Q. Zhang, “Effect of scorpion venom on the expression of proenkephalin in C57BL/6 mice with Parkinson disease,” Zhong Guo Linchuang Kangfu, vol. 10, no. 19, pp. 33–36, 2006. View at Google Scholar · View at Scopus